Steven Powell has been appointed director and partner of Gilde Biotechnology and Nutrition Fund. Powell has over 18 years’ experience in the pharmaceutical and biotechnology industry. He joins Gilde from KS Biomedix Holdings, a biopharmaceutical company listed on the London Stock Exchange, where he was CEO. In this role he was responsible for building a late stage clinical development pipeline through organic development, licensing and corporate acquisition and he led two financing rounds in the London capital market. Prior to this he was CEO at Actinova, a subsidiary of the Swedish biopharmaceutical company, Active Biotech.